ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

Pharmaceutical

Therapeutics

ATXA Therapeutics

ATXA Therapeutics' headquarters in Blackrock, Ireland

Therese Kinsella

Helen Reid

Eamon Mulvaney

Andy Baxter

Mark Maginn

Diarmuid Burke

Mike Perkins

Daniel O'Mahony

Adriaan Fruijtier

Jonathan Langley

The Scientific Team at ATXA Therapeutics is dedicated to advancing the late-stage preclinical and clinical development of innovative small molecule drugs for treating Pulmonary Arterial Hypertension. Comprising Senior Scientist, Program Manager & Scientist, and Research Scientist, the team conducts rigorous research, designs and manages experimental protocols, and ensures seamless progression from preclinical trials to clinical applications.

Scientific Team

ATXA Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Offices

ATXA Therapeutics

Org chart

Board & advisors

Teams

Scientific Team

Offices

Related companies